Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum (Q73819807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum (English)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70170-1

21 November 2024

G. W. Elgart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344192

21 November 2024

W. Sheremata

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344192

21 November 2024

Y. S. Ahn

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344192

21 November 2024

language of work or name

English

0 references

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9344192

full work available at URL

21 November 2024

https://doi.org/10.1016/s0190-9622(97)70170-1

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9344192

https://api.elsevier.com/content/article/PII:S0190962297701701?httpAccept=text/xml

21 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70170-1

https://api.elsevier.com/content/article/PII:S0190962297701701?httpAccept=text/plain

21 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70170-1

Journal of the American Academy of Dermatology

21 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

553-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

Clinical trials of interferons in multiple sclerosis. What have we learned?

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Interferons in multiple sclerosis. A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Encephalitogenic peptide and platelet aggregation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Warfarin-induced skin necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Skin necrosis following warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Thrombotic vasculopathy associated with cryofibrinogenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Purpura and recurrent ulcers on the lower extremities. Essential cryofibrinogenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Purpura fulminans due to protein S deficiency following chickenpox

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Purpura and gangrene in a septic patient. Purpura fulminans secondary to pneumococcal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Answers to the antiphospholipid-antibody syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Disseminated intravascular coagulation. Approach to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970170-1

7 January 2021

Effects on platelet function by human interferon-beta in carcinoma patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70170-1

Widespread cutaneous necrosis as the initial manifestation of the antiphospholipid antibody syndrome

21 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70170-1

21 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9344192%20AND%20SRC:MED&resulttype=core&format=json